Daunorubicin in the therapy of acute granulocytic leukemia

Cancer Res. 1973 May;33(5):921-8.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Blood Platelets
  • Blood Transfusion
  • Cytarabine / therapeutic use
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects
  • Daunorubicin / therapeutic use*
  • Female
  • Humans
  • Hydrazines / therapeutic use
  • Hyperplasia / chemically induced
  • Leukemia, Myeloid / blood
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / therapy
  • Leukocyte Count
  • Leukopenia / chemically induced
  • Male
  • Mercaptopurine / therapeutic use
  • Methotrexate / therapeutic use
  • Middle Aged
  • Remission, Spontaneous
  • Thrombocytopenia / chemically induced
  • Time Factors

Substances

  • Hydrazines
  • Cytarabine
  • Mercaptopurine
  • Methotrexate
  • Daunorubicin